| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |